 | Up a level |
Dibitetto, Diego; Widmer, Carmen A; Rottenberg, Sven (2024). PARPi, BRCA, and gaps: controversies and future research. Trends in cancer, 10(9), pp. 857-869. Elsevier 10.1016/j.trecan.2024.06.008
Aronson, S Lot; Walker, Cédric; Thijssen, Bram; van de Vijver, Koen K; Horlings, Hugo M; Sanders, Joyce; Alkemade, Maartje; Koole, Simone N; Lopez-Yurda, Marta; Lok, Christianne A R; Rottenberg, Sven; van Rheenen, Jacco; Sonke, Gabe S; van Driel, Willemien J; Kester, Lennart A; Hahn, Kerstin (2024). Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1). British journal of cancer, 131(3), pp. 565-576. Springer Nature 10.1038/s41416-024-02731-6
Maurizio, Marina; Masid, Maria; Woods, Kerry; Caldelari, Reto; Doench, John G; Naguleswaran, Arunasalam; Joly, Denis; González-Fernández, Martín; Zemp, Jonas; Borteele, Mélanie; Hatzimanikatis, Vassily; Heussler, Volker; Rottenberg, Sven; Olias, Philipp (2024). Host cell CRISPR genomics and modelling reveal shared metabolic vulnerabilities in the intracellular development of Plasmodium falciparum and related hemoparasites. Nature Communications, 15(1) Springer Nature 10.1038/s41467-024-50405-x
Lo Giudice, Adriana; Porcellato, Ilaria; Pellegrini, Martina; Rottenberg, Sven; He, Chang; Dentini, Alfredo; Moretti, Giulia; Cagiola, Monica; Mechelli, Luca; Chiaradia, Elisabetta; Brachelente, Chiara (2024). Establishment of Primary Cell Cultures from Canine Oral Melanomas via Fine-Needle Aspiration: A Novel Tool for Tumorigenesis and Cancer Progression Studies. Animals, 14(13) MDPI 10.3390/ani14131948
Jankovic, Jana; Tièche, Eve; Dettwiler, Martina; Hahn, Kerstin; Scheemaeker, Stephanie; Kessler, Martin; Daminet, Sylvie; Rottenberg, Sven; Campos, Miguel (2024). Canine follicular cell and medullary thyroid carcinomas: Immunohistochemical characterization. Veterinary pathology, 61(4), pp. 524-533. Sage 10.1177/03009858231217245
Walker, Cédric; Talawalla, Tasneem; Toth, Robert; Ambekar, Akhil; Rea, Kien; Chamian, Oswin; Fan, Fan; Berezowska, Sabina; Rottenberg, Sven; Madabhushi, Anant; Maillard, Marie; Barisoni, Laura; Horlings, Hugo Mark; Janowczyk, Andrew (2024). PatchSorter: a high throughput deep learning digital pathology tool for object labeling. NPJ digital medicine, 7(1) Nature Publishing Group 10.1038/s41746-024-01150-4
Brühlmann, Francis; Perry, Carmen; Griessen, Charlotte; Gunasekera, Kapila; Reymond, Jean-Louis; Naguleswaran, Arunasalam; Rottenberg, Sven; Woods, Kerry; Olias, Philipp (2024). TurboID mapping reveals the exportome of secreted intrinsically disordered proteins in the transforming parasite Theileria annulata. mBio, 15(6), e0341223. American Society for Microbiology 10.1128/mbio.03412-23
Aeschlimann, Leonore; Kehl, Alexandra; Guscetti, Franco; Posthaus, Caroline; Aupperle-Lellbach, Heike; Rottenberg, Sven; De Brot, Simone (2024). Effective detection of BRAFV595E mutation in canine urothelial and prostate carcinomas using immunohistochemistry. Veterinary and comparative oncology, 22(2), pp. 295-302. Wiley 10.1111/vco.12978
Dibitetto, Diego; Liptay, Martin; Vivalda, Francesca; Dogan, Hülya; Gogola, Ewa; González Fernández, Martín; Duarte, Alexandra; Schmid, Jonas A; Decollogny, Morgane Francine; Francica, Paola; Przetocka, Sara; Durant, Stephen T; Forment, Josep V; Klebic, Ismar; Siffert, Myriam; de Bruijn, Roebi; Kousholt, Arne N; Marti, Nicole A; Dettwiler, Martina; Sørensen, Claus S; ... (2024). H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours. Nature communications, 15(4430) Nature Publishing Group 10.1038/s41467-024-48715-1
Decollogny, Morgane; Rottenberg, Sven (2024). Persisting cancer cells are different from bacterial persisters. Trends in cancer, 10(5), pp. 393-406. Elsevier 10.1016/j.trecan.2024.02.002
Akhoundova, Dilara; Francica, Paola; Rottenberg, Sven; Rubin, Mark A (2024). DNA Damage Response and Mismatch Repair Gene Defects in Advanced and Metastatic Prostate Cancer. Advances in anatomic pathology, 31(2), pp. 61-69. Lippincott Williams & Wilkins 10.1097/PAP.0000000000000422
Andronikou, Christina; Burdova, Kamila; Dibitetto, Diego; Lieftink, Cor; Malzer, Elke; Kuiken, Hendrik J; Gogola, Ewa; Ray Chaudhuri, Arnab; Beijersbergen, Roderick L; Hanzlikova, Hana; Jonkers, Jos; Rottenberg, Sven (2024). PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair. The EMBO journal, 43(6), pp. 1015-1042. EMBO Press 10.1038/s44318-024-00043-2
Dibitetto, Diego; Rottenberg, Sven (2024). DNA repair, gap suppression, or fork protection: BRCA2 needs a break! Molecular cell, 84(3), pp. 409-410. Cell Press 10.1016/j.molcel.2023.12.026
Valdeolivas, Alberto; Amberg, Bettina; Giroud, Nicolas; Richardson, Marion; Gálvez, Eric J C; Badillo, Solveig; Julien-Laferrière, Alice; Túrós, Demeter; Voith von Voithenberg, Lena; Wells, Isabelle; Pesti, Benedek; Lo, Amy A; Yángüez, Emilio; Das Thakur, Meghna; Bscheider, Michael; Sultan, Marc; Kumpesa, Nadine; Jacobsen, Björn; Bergauer, Tobias; Saez-Rodriguez, Julio; ... (2024). Profiling the heterogeneity of colorectal cancer consensus molecular subtypes using spatial transcriptomics. NPJ precision oncology, 8(1), p. 10. Springer Nature 10.1038/s41698-023-00488-4
Küchler, Leonore; Posthaus, Caroline; Jäger, Kathrin; Guscetti, Franco; van der Weyden, Louise; von Bomhard, Wolf; Schmidt, Jarno M; Farra, Dima; Aupperle-Lellbach, Heike; Kehl, Alexandra; Rottenberg, Sven; de Brot, Simone (2023). Artificial Intelligence to Predict the BRAF V595E Mutation in Canine Urinary Bladder Urothelial Carcinomas. Animals, 13(15) MDPI 10.3390/ani13152404
Zelceski, Anabel; Francica, Paola; Lingg, Lea; Mutlu, Merve; Stok, Colin; Liptay, Martin; Alexander, John; Baxter, Joseph S; Brough, Rachel; Gulati, Aditi; Haider, Syed; Raghunandan, Maya; Song, Feifei; Sridhar, Sandhya; Forment, Josep V; O'Connor, Mark J; Davies, Barry R; van Vugt, Marcel A T M; Krastev, Dragomir B; Pettitt, Stephen J; ... (2023). MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells. Cell reports, 42(5), p. 112484. Cell Press 10.1016/j.celrep.2023.112484
Bhin, Jinhyuk; Paes Dias, Mariana; Gogola, Ewa; Rolfs, Frank; Piersma, Sander R; de Bruijn, Roebi; de Ruiter, Julian R; van den Broek, Bram; Duarte, Alexandra A; Sol, Wendy; van der Heijden, Ingrid; Andronikou, Christina; Kaiponen, Taina S; Bakker, Lara; Lieftink, Cor; Morris, Ben; Beijersbergen, Roderick L; van de Ven, Marieke; Jimenez, Connie R; Wessels, Lodewyk F A; ... (2023). Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors. Cell reports, 42(5), p. 112538. Cell Press 10.1016/j.celrep.2023.112538
Scheemaeker, Stephanie; Inglebert, Marine; Daminet, Sylvie; Dettwiler, Martina; Letko, Anna; Drögemüller, Cord; Kessler, Martin; Ducatelle, Richard; Rottenberg, Sven; Campos, Miguel (2023). Organoids of patient-derived medullary thyroid carcinoma: the first milestone towards a new in vitro model in dogs. Veterinary and comparative oncology, 21(1), pp. 111-122. Wiley 10.1111/vco.12872
Gradauskaite, Vaiva; Inglebert, Marine; Doench, John; Scherer, Melanie; Dettwiler, Martina; Wyss, Marianne; Shrestha, Neeta; Rottenberg, Sven; Plattet, Philippe (2023). LRP6 Is a Functional Receptor for Attenuated Canine Distemper Virus. mBio, 14(1), e0311422. American Society for Microbiology 10.1128/mbio.03114-22
Monod, Anne; Koch, Christoph; Jindra, Christoph; Haspeslagh, Maarten; Howald, Denise; Wenker, Christian; Gerber, Vinzenz; Rottenberg, Sven; Hahn, Kerstin (2023). CRISPR/Cas9-Mediated Targeting of BPV-1-Transformed Primary Equine Sarcoid Fibroblasts. Viruses, 15(9), p. 1942. MDPI 10.3390/v15091942
Inglebert, Marine; Dettwiler, Martina; Hahn, Kerstin; Letko, Anna; Drögemüller, Cord; Doench, John; Brown, Adam; Memari, Yasin; Davies, Helen R; Degasperi, Andrea; Nik-Zainal, Serena; Rottenberg, Sven (2022). A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer. Scientific Reports, 12(1), p. 18051. Nature Publishing Group 10.1038/s41598-022-21706-2
Dibitetto, Diego; Marshall, Shannon; Sanchi, Andrea; Liptay, Martin; Badar, Jumana; Lopes, Massimo; Rottenberg, Sven; Smolka, Marcus B (2022). DNA-PKcs promotes fork reversal and chemoresistance. Molecular cell, 82(20), 3932-3942.e6. Cell Press 10.1016/j.molcel.2022.08.028
Janowczyk, Andrew; Baumhoer, Daniel; Dirnhofer, Stefan; Grobholz, Rainer; Kipar, Anja; de Leval, Laurence; Merkler, Doron; Michielin, Olivier; Moch, Holger; Perren, Aurel; Rottenberg, Sven; Rubbia-Brandt, Laura; Rubin, Mark A; Sempoux, Christine; Tolnay, Markus; Zlobec, Inti; Koelzer, Viktor Hendrik (2022). Towards a national strategy for digital pathology in Switzerland. Virchows Archiv, 481(4), pp. 647-652. Springer 10.1007/s00428-022-03345-0
Zingg, Daniel; Bhin, Jinhyuk; Yemelyanenko, Julia; Kas, Sjors M; Rolfs, Frank; Lutz, Catrin; Lee, Jessica K; Klarenbeek, Sjoerd; Silverman, Ian M; Annunziato, Stefano; Chan, Chang S; Piersma, Sander R; Eijkman, Timo; Badoux, Madelon; Gogola, Ewa; Siteur, Bjørn; Sprengers, Justin; de Klein, Bim; de Goeij-de Haas, Richard R; Riedlinger, Gregory M; ... (2022). Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers. Nature, 609(7929), E13. Springer Nature 10.1038/s41586-022-05287-8
Zingg, Daniel; Bhin, Jinhyuk; Yemelyanenko, Julia; Kas, Sjors M; Rolfs, Frank; Lutz, Catrin; Lee, Jessica K; Klarenbeek, Sjoerd; Silverman, Ian M; Annunziato, Stefano; Chan, Chang S; Piersma, Sander R; Eijkman, Timo; Badoux, Madelon; Gogola, Ewa; Siteur, Bjørn; Sprengers, Justin; de Klein, Bim; de Goeij-de Haas, Richard R; Riedlinger, Gregory M; ... (2022). Truncated FGFR2 is a clinically actionable oncogene in multiple cancers. Nature, 608(7923), pp. 609-617. Springer Nature 10.1038/s41586-022-05066-5
Paes Dias, Mariana; Rottenberg, Sven; Jonkers, Jos (2022). Functional genetic dropout screens and in vivo validation of candidate therapeutic targets using mouse mammary tumoroids. STAR protocols, 3(1), p. 101132. Elsevier 10.1016/j.xpro.2022.101132
Lingg, Lea; Rottenberg, Sven; Francica, Paola (2022). Meiotic genes and DNA double strand break repair in cancer. Frontiers in genetics, 13 Frontiers Media SA 10.3389/fgene.2022.831620
Widmer, Carmen A; Klebic, Ismar; Domanitskaya, Natalya; Decollogny, Morgane Francine; Howald, Denise; Siffert, Myriam; Essers, Paul; Nowicka, Zuzanna; Stokar-Regenscheit, Nadine; van de Ven, Marieke; de Korte-Grimmerink, Renske; Galván, José A; Pritchard, Colin E.J.; Huijbers, Ivo J; Fendler, Wojciech; Vens, Conchita; Rottenberg, Sven (2022). Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy. Cancer research communications, 2(10), pp. 1266-1281. American Association for Cancer Research 10.1158/2767-9764.CRC-22-0208
Paes Dias, Mariana; Tripathi, Vivek; van der Heijden, Ingrid; Cong, Ke; Manolika, Eleni-Maria; Bhin, Jinhyuk; Gogola, Ewa; Galanos, Panagiotis; Annunziato, Stefano; Lieftink, Cor; Andújar-Sánchez, Miguel; Chakrabarty, Synjiban; Smith, Graeme C. M.; van de Ven, Marieke; Beijersbergen, Roderick; Bartkova, Jirina; Rottenberg, Sven; Cantor, Sharon; Bartek, Jiri; Chaudhuri, Arnab Ray; ... (2021). Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps. Molecular cell, 81(22), pp. 4692-4708. Cell Press 10.1016/j.molcel.2021.09.005
Jankovic, Jana; Dettwiler, Martina; González Fernández, Martin; Tièche, Eve; Hahn, Kerstin; April-Monn, Simon; Dettmer, Matthias S; Kessler, Martin; Rottenberg, Sven; Campos, Miguel (2021). Validation of Immunohistochemistry for Canine Proteins Involved in Thyroid Iodine Uptake and Their Expression in Canine Follicular Cell Thyroid Carcinomas (FTCs) and FTC-Derived Organoids. Veterinary pathology, 58(6), pp. 1172-1180. Sage 10.1177/03009858211018813
Andronikou, Christina; Rottenberg, Sven (2021). Studying PAR-Dependent Chromatin Remodeling to Tackle PARPi Resistance. Trends in molecular medicine, 27(7), pp. 630-642. Cell Press 10.1016/j.molmed.2021.04.010
Rottenberg, Sven; Disler, Carmen; Perego, Paola (2021). The rediscovery of platinum-based cancer therapy. Nature reviews - cancer, 21(1), pp. 37-50. Nature Publishing Group 10.1038/s41568-020-00308-y
Franica, Paola; Mutlu, Merve; Blomen, Vincent A.; Oliveira, Catarina; Nowicka, Zuzanna; Trenner, Anika; Gerhards, Nora M.; Bouwman, Peter; Stickel, Elmer; Hekkelman, Maarten L.; Lingg, Lea; Klebic, Ismar; van den Ven, Marieke; de Korte-Grimmerink, Renske; Howald, Denise; Jonkers, Jos; Sartori, Alessandro A.; Fendler, Wojciech; Chapman, J. Ross; Brummelkamp, Thijn; ... (2020). Functional radiogenetic profiling implicates ERCC6L2 in non-homologous end joining. Cell reports, 32(8), p. 108068. Cell Press 10.1016/j.celrep.2020.108068
Benvegnen, Jennifer; De Breuyn, Bettina; Gerber, Vinzenz; Rottenberg, Sven; Koch, Christoph (2020). Immunohistochemical analysis of programmed death-ligand 1 expression in equine sarcoids. Journal of equine veterinary science, 97, p. 103338. Elsevier 10.1016/j.jevs.2020.103338
Liptay, Martin; Barbosa, Joana S.; Rottenberg, Sven (2020). Replication Fork Remodeling and Therapy Escape in DNA Damage Response-Deficient Cancers. Frontiers in oncology, 10, p. 670. Frontiers Research Foundation 10.3389/fonc.2020.00670
Pantelidou, Constantia; Sonzogni, Olmo; de Oliveira Taveira, Mateus; Mehta, Anita K; Kothari, Aditi; Wang, Dan; Visal, Tanvi; Li, Michelle K; Pinto, Jocelin; Castrillon, Jessica A; Cheney, Emily M; Bouwman, Peter; Jonkers, Jos; Rottenberg, Sven; Guerriero, Jennifer L; Wulf, Gerburg M; Shapiro, Geoffrey I (2019). PARP inhibitor efficacy depends on CD8+ T cell recruitment via intratumoral STING pathway activation in BRCA-deficient models of triple-negative breast cancer. Cancer discovery, 9(6), pp. 722-737. American Association for Cancer Research 10.1158/2159-8290.CD-18-1218
Barazas, Marco; Gasparini, Alessia; Huang, Yike; Küçükosmanoğlu, Asli; Annunziato, Stefano; Bouwman, Peter; Sol, Wendy; Kersbergen, Ariena; Proost, Natalie; de Korte-Grimmerink, Renske; van de Ven, Marieke; Jonkers, Jos; Borst, Gerben R; Rottenberg, Sven (2019). Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient Tumors. Cancer research, 79(3), pp. 452-460. American Association for Cancer Research AACR 10.1158/0008-5472.CAN-18-2077
Francica, Paola; Rottenberg, Sven (2018). Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response. Genome medicine, 10(1), p. 101. BioMed Central 10.1186/s13073-018-0612-8
Becker, Jordan R; Cuella-Martin, Raquel; Barazas, Marco; Liu, Rui; Oliveira, Catarina; Oliver, Antony W; Bilham, Kirstin; Holt, Abbey B; Blackford, Andrew N; Heierhorst, Jörg; Jonkers, Jos; Rottenberg, Sven; Chapman, J Ross (2018). The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity. Nature communications, 9(1), p. 5406. Nature Publishing Group 10.1038/s41467-018-07855-x
Dettwiler, Martina Andrea; Mehinagic, Kemal; Gobeli, Stefanie; Thomann, Andreas; Feyer, Simon; Hüsser, Linda; Theubet, G; Gigandet, J; Rottenberg, Sven; Posthaus, Horst (2018). Bacillus anthracis as a cause of bovine abortion - a necropsy case requiring special biosafety measures. Schweizer Archiv für Tierheilkunde, 160(9), pp. 547-552. Gesellschaft Schweizer Tierärztinnen und Tierärzte 10.17236/sat00176
Ghezraoui, Hind; Oliveira, Catarina; Becker, Jordan R; Bilham, Kirstin; Moralli, Daniela; Anzilotti, Consuelo; Fischer, Roman; Deobagkar-Lele, Mukta; Sanchiz-Calvo, Maria; Fueyo-Marcos, Elena; Bonham, Sarah; Kessler, Benedikt M; Rottenberg, Sven; Cornall, Richard J; Green, Catherine M; Chapman, J Ross (2018). 53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJ. Nature, 560(7716), pp. 122-127. Macmillan Journals Ltd. 10.1038/s41586-018-0362-1
Noordermeer, Sylvie M; Adam, Salomé; Setiaputra, Dheva; Barazas, Marco; Pettitt, Stephen J; Ling, Alexanda K; Olivieri, Michele; Álvarez-Quilón, Alejandro; Moatti, Nathalie; Zimmermann, Michal; Annunziato, Stefano; Krastev, Dragomir B; Song, Feifei; Brandsma, Inger; Frankum, Jessica; Brough, Rachel; Sherker, Alana; Landry, Sébastien; Szilard, Rachel K; Munro, Meagan M; ... (2018). The shieldin complex mediates 53BP1-dependent DNA repair. Nature, 560(7716), pp. 117-121. Macmillan Journals Ltd. 10.1038/s41586-018-0340-7
Gogola, Ewa; Duarte, Alexandra A; de Ruiter, Julian R; Wiegant, Wouter W; Schmid, Jonas A; de Bruijn, Roebi; James, Dominic I; Guerrero Llobet, Sergi; Vis, Daniel J; Annunziato, Stefano; van den Broek, Bram; Barazas, Marco; Kersbergen, Ariena; van de Ven, Marieke; Tarsounas, Madalena; Ogilvie, Donald J; van Vugt, Marcel; Wessels, Lodewyk F A; Bartkova, Jirina; Gromova, Irina; ... (2018). Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality. Cancer cell, 33(6), 1078-1093.e12. Cell Press 10.1016/j.ccell.2018.05.008
Barazas, Marco; Annunziato, Stefano; Pettitt, Stephen J; de Krijger, Inge; Ghezraoui, Hind; Roobol, Stefan J; Lutz, Catrin; Frankum, Jessica; Song, Fei Fei; Brough, Rachel; Evers, Bastiaan; Gogola, Ewa; Bhin, Jinhyuk; van de Ven, Marieke; van Gent, Dik C; Jacobs, Jacqueline J L; Chapman, Ross; Lord, Christopher J; Jonkers, Jos and Rottenberg, Sven (2018). The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells. Cell reports, 23(7), pp. 2107-2118. Cell Press 10.1016/j.celrep.2018.04.046
Gerhards, Nora Merete; Blomen, Vincent A; Mutlu, Merve; Nieuwenhuis, Joppe; Howald, Denise; Guyader, Charlotte; Jonkers, Jos; Brummelkamp, Thijn R; Rottenberg, Sven (2018). Haploid genetic screens identify genetic vulnerabilities to microtubule-targeting agents. Molecular oncology, 12(6), pp. 953-971. Elsevier 10.1002/1878-0261.12307
Meghani, Khyati; Fuchs, Walker; Detappe, Alexandre; Drané, Pascal; Gogola, Ewa; Rottenberg, Sven; Jonkers, Jos; Matulonis, Ursula; Swisher, Elizabeth M; Konstantinopoulos, Panagiotis A; Chowdhury, Dipanjan (2018). Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated Carcinomas. Cell reports, 23(1), pp. 100-111. Cell Press 10.1016/j.celrep.2018.03.038
Duarte, Alexandra A; Gogola, Ewa; Sachs, Norman; Barazas, Marco; Annunziato, Stefano; R de Ruiter, Julian; Velds, Arno; Blatter, Sohvi Tuulikki; Houthuijzen, Julia M; van de Ven, Marieke; Clevers, Hans; Borst, Piet; Jonkers, Jos; Rottenberg, Sven (2018). BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance. Nature methods, 15(2), pp. 134-140. Nature Publishing Group 10.1038/nmeth.4535
Sachs, Norman; de Ligt, Joep; Kopper, Oded; Gogola, Ewa; Bounova, Gergana; Weeber, Fleur; Balgobind, Anjali Vanita; Wind, Karin; Gracanin, Ana; Begthel, Harry; Korving, Jeroen; van Boxtel, Ruben; Duarte, Alexandra Alves; Lelieveld, Daphne; van Hoeck, Arne; Ernst, Robert Frans; Blokzijl, Francis; Nijman, Isaac Johannes; Hoogstraat, Marlous; van de Ven, Marieke; ... (2018). A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity. Cell, 172(1-2), pp. 373-386. Cell Press 10.1016/j.cell.2017.11.010
Gerhards, Nora Merete; Rottenberg, Sven (2018). New tools for old drugs: Functional genetic screens to optimize current chemotherapy. Drug Resistance Updates, 36, pp. 30-46. Elsevier 10.1016/j.drup.2018.01.001
Pajic, Marina; Blatter, Sohvi Tuulikki; Guyader, Charlotte; Gonggrijp, Maaike; Kersbergen, Ariena; Küçükosmanoğlu, Aslι; Sol, Wendy; Drost, Rinske; Jonkers, Jos; Borst, Piet; Rottenberg, Sven (2017). Selected Alkylating Agents Can Overcome Drug Tolerance of G-like Tumor Cells and Eradicate BRCA1-Deficient Mammary Tumors in Mice. Clinical cancer research, 23(22), pp. 7020-7033. American Association for Cancer Research 10.1158/1078-0432.CCR-17-1279
Rondinelli, Beatrice; Gogola, Ewa; Yücel, Hatice; Duarte, Alexandra A; van de Ven, Marieke; van der Sluijs, Roxanne; Konstantinopoulos, Panagiotis A; Jonkers, Jos; Ceccaldi, Raphaël; Rottenberg, Sven; D'Andrea, Alan D (2017). EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation. Nature cell biology, 19(11), pp. 1371-1378. Nature Publishing Group 10.1038/ncb3626
Borst, Gerben R; Kumareswaran, Ramya; Yücel, Hatice; Telli, Seyda; Do, Trevor; McKee, Trevor; Zafarana, Gaetano; Jonkers, Jos; Verheij, Marcel; O'Connor, Mark J; Rottenberg, Sven; Bristow, Robert G (2017). Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model. OncoTarget, 8(50), pp. 87638-87646. Impact Journals LLC 10.18632/oncotarget.20936
Schoonen, Pepijn M; Talens, Francien; Stok, Colin; Gogola, Ewa; Heijink, Anne Margriet; Bouwman, Peter; Foijer, Floris; Tarsounas, Madalena; Blatter, Sohvi Tuulikki; Jonkers, Jos; Rottenberg, Sven; van Vugt, Marcel A T M (2017). Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cells. Nature communications, 8(15981), p. 15981. Nature Publishing Group 10.1038/ncomms15981
Annunziato, Stefano; Barazas, Marco; Rottenberg, Sven; Jonkers, Jos (2016). Genetic Dissection of Cancer Development, Therapy Response, and Resistance in Mouse Models of Breast Cancer. Cold Spring Harbor Symposia on Quantitative Biology, 81, pp. 141-150. Biological Laboratory 10.1101/sqb.2016.81.030924
Oplustil O'Connor, Lenka; Rulten, Stuart L; Cranston, Aaron N; Odedra, Rajesh; Brown, Henry; Jaspers, Janneke E; Jones, Louise; Knights, Charlotte; Evers, Bastiaan; Ting, Attilla; Bradbury, Robert H; Pajic, Marina; Rottenberg, Sven; Jonkers, Jos; Rudge, David; Martin, Niall M B; Caldecott, Keith W; Lau, Alan; O'Connor, Mark J (2016). The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models. Cancer research, 76(20), pp. 6084-6094. American Association for Cancer Research AACR 10.1158/0008-5472.CAN-15-3240
Warmoes, Marc; Lam, Siu W; van der Groep, Petra; Jaspers, Janneke E; Smolders, Yvonne H C M; de Boer, Leon; Pham, Thang V; Piersma, Sander R; Rottenberg, Sven; Boven, Epie; Jonkers, Jos; van Diest, Paul J; Jimenez, Connie R (2016). Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer. OncoTarget, 7(39), pp. 63537-63548. Impact Journals LLC 10.18632/oncotarget.11535
Drost, Rinske; Dhillon, Kiranjit K; van der Gulden, Hanneke; van der Heijden, Ingrid; Brandsma, Inger; Cruz, Cristina; Chondronasiou, Dafni; Castroviejo-Bermejo, Marta; Boon, Ute; Schut, Eva; van der Burg, Eline; Wientjens, Ellen; Pieterse, Mark; Klijn, Christiaan; Klarenbeek, Sjoerd; Loayza-Puch, Fabricio; Elkon, Ran; van Deemter, Liesbeth; Rottenberg, Sven; van de Ven, Marieke; ... (2016). BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1. Journal of clinical investigation, 126(8), pp. 2903-2918. American Society for Clinical Investigation 10.1172/JCI70196
Ray Chaudhuri, Arnab; Callen, Elsa; Ding, Xia; Gogola, Ewa; Duarte, Alexandra A; Lee, Ji-Eun; Wong, Nancy; Lafarga, Vanessa; Calvo, Jennifer A; Panzarino, Nicholas J; John, Sam; Day, Amanda; Crespo, Anna Vidal; Shen, Binghui; Starnes, Linda M; de Ruiter, Julian R; Daniel, Jeremy A; Konstantinopoulos, Panagiotis A; Cortez, David; Cantor, Sharon B; ... (2016). Replication fork stability confers chemoresistance in BRCA-deficient cells. Nature, 535(7612), pp. 382-387. Macmillan Journals Ltd. 10.1038/nature18325
Tkáč, Ján; Xu, Guotai; Adhikary, Hemanta; Young, Jordan T F; Gallo, David; Escribano-Díaz, Cristina; Krietsch, Jana; Orthwein, Alexandre; Munro, Meagan; Sol, Wendy; Al-Hakim, Abdallah; Lin, Zhen-Yuan; Jonkers, Jos; Borst, Piet; Brown, Grant W; Gingras, Anne-Claude; Rottenberg, Sven; Masson, Jean-Yves; Durocher, Daniel (2016). HELB Is a Feedback Inhibitor of DNA End Resection. Molecular cell, 61(3), pp. 405-418. Cell Press 10.1016/j.molcel.2015.12.013
Hendrikx, Jeroen J M A; Lagas, Jurjen S; Song, Ji-Ying; Rosing, Hilde; Schellens, Jan H M; Beijnen, Jos H; Rottenberg, Sven; Schinkel, Alfred H (2016). Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model. International journal of cancer, 138(3), pp. 758-769. Wiley-Blackwell 10.1002/ijc.29812
Planells-Cases, Rosa; Lutter, Darius; Guyader, Charlotte; Gerhards, Nora Merete; Ullrich, Florian; Elger, Deborah A; Kucukosmanoglu, Asli; Xu, Guotai; Voss, Felizia K; Reincke, S Momsen; Stauber, Tobias; Blomen, Vincent A; Vis, Daniel J; Wessels, Lodewyk F; Brummelkamp, Thijn R; Borst, Piet; Rottenberg, Sven; Jentsch, Thomas J (2015). Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs. The EMBO Journal, 34(24), pp. 2993-3008. EMBO Press 10.15252/embj.201592409
Yu, Huixin; Hendrikx, Jeroen J M A; Rottenberg, Sven; Schellens, Jan H M; Beijnen, Jos H; Huitema, Alwin D R (2015). Development of a Tumour Growth Inhibition Model to Elucidate the Effects of Ritonavir on Intratumoural Metabolism and Anti-tumour Effect of Docetaxel in a Mouse Model for Hereditary Breast Cancer. AAPS journal, 18(2), pp. 362-371. American Association of Pharmaceutical Scientists 10.1208/s12248-015-9838-1
Henneman, Linda; van Miltenburg, Martine H; Michalak, Ewa M; Braumuller, Tanya M; Jaspers, Janneke E; Drenth, Anne Paulien; de Korte-Grimmerink, Renske; Gogola, Ewa; Szuhai, Karoly; Schlicker, Andreas; Bin Ali, Rahmen; Pritchard, Colin; Huijbers, Ivo J; Berns, Anton; Rottenberg, Sven; Jonkers, Jos (2015). Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer. Proceedings of the National Academy of Sciences of the United States of America - PNAS, 112(27), pp. 8409-8414. National Academy of Sciences NAS 10.1073/pnas.1500223112
Nachabé, Rami; Hendriks, Benno H W; Schierling, Ross; Hales, Jasmine; Racadio, Judy M; Rottenberg, Sven; Ruers, Theo J M; Babic, Drazenko; Racadio, John M (2015). Real-Time In Vivo Characterization of Primary Liver Tumors With Diffuse Optical Spectroscopy During Percutaneous Needle Interventions: Feasibility Study in Woodchucks. Investigative radiology, 50(7), pp. 443-448. Lippincott Williams & Wilkins 10.1097/RLI.0000000000000149
Xu, Guotai; Chapman, J Ross; Brandsma, Inger; Yuan, Jingsong; Mistrik, Martin; Bouwman, Peter; Bartkova, Jirina; Gogola, Ewa; Warmerdam, Daniël; Barazas, Marco; Jaspers, Janneke E; Watanabe, Kenji; Pieterse, Mark; Kersbergen, Ariena; Sol, Wendy; Celie, Patrick H N; Schouten, Philip C; van den Broek, Bram; Salman, Ahmed; Nieuwland, Marja; ... (2015). REV7 counteracts DNA double-strand break resection and affects PARP inhibition. Nature, 521(7553), pp. 541-544. Macmillan Journals Ltd. 10.1038/nature14328
Jaspers, Janneke E; Sol, Wendy; Kersbergen, Ariena; Schlicker, Andreas; Guyader, Charlotte; Xu, Guotai; Wessels, Lodewyk; Borst, Piet; Jonkers, Jos; Rottenberg, Sven (2015). BRCA2-Deficient Sarcomatoid Mammary Tumors Exhibit Multidrug Resistance. Cancer research, 75(4), pp. 732-741. American Association for Cancer Research AACR 10.1158/0008-5472.CAN-14-0839
Kuilman, Thomas; Velds, Arno; Kemper, Kristel; Ranzani, Marco; Bombardelli, Lorenzo; Hoogstraat, Marlous; Nevedomskaya, Ekaterina; Xu, Guotai; de Ruiter, Julian; Lolkema, Martijn P; Ylstra, Bauke; Jonkers, Jos; Rottenberg, Sven; Wessels, Lodewyk F; Adams, David J; Peeper, Daniel S; Krijgsman, Oscar (2015). CopywriteR: DNA copy number detection from off-target sequence data. Genome biology, 16(49), p. 49. BioMed Central Ltd. 10.1186/s13059-015-0617-1
Blatter, Sohvi; Rottenberg, Sven (2015). Minimal residual disease in cancer therapy - Small things make all the difference. Drug Resistance Updates, 21-22, pp. 1-10. Churchill Livingstone 10.1016/j.drup.2015.08.003
van Asten, Jack J A; Vettukattil, Riyas; Buckle, Tessa; Rottenberg, Sven; van Leeuwen, Fijs; Bathen, Tone F; Heerschap, Arend (2015). Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy. Journal of translational medicine, 13(114), p. 114. BioMed Central 10.1186/s12967-015-0458-4
Spliethoff, Jarich W; Evers, Daniel J; Jaspers, Janneke E; Hendriks, Benno H W; Rottenberg, Sven; Ruers, Theo J M (2014). Monitoring of tumor response to Cisplatin using optical spectroscopy. Translational oncology, 7(2), pp. 230-239. Elsevier 10.1016/j.tranon.2014.02.009
Dobbelaere, Dirk; Rottenberg, Sven (2003). Theileria-induced leukocyte transformation. Current opinion in microbiology, 6(4), pp. 377-382. London: Current Biology Ltd. 10.1016/S1369-5274(03)00085-7
Xu, Guotai; Jonkers, Jos; Rottenberg, Sven (2015). PARP Inhibitor Resistance - What Is Beyond BRCA1 or BRCA2 Restoration? In: Curtin, Nicola J.; Sharma, Ricky A. (eds.) PARP Inhibitor Resistance—What Is Beyond BRCA1 or BRCA2 Restoration? Cancer Drug Discovery and Development: Vol. 83 (pp. 453-471). Cham: Springer International Publishing 10.1007/978-3-319-14151-0_19
Jaume, Guillaume; De Brot, Simone; Song, Andrew H; Williamson, Drew F K; Oldenburg, Lukas; Zhang, Andrew; Chen, Richard J; Asin, Javier; Blatter, Sohvi; Dettwiler, Martina; Goepfert, Christine; Grau-Roma, Llorenç; Soto, Sara; Keller, Stefan M; Rottenberg, Sven; Del-Pozo, Jorge; Pettit, Rowland; Le, Long Phi; Mahmood, Faisal (23 July 2024). Deep Learning-based Modeling for Preclinical Drug Safety Assessment. (bioRxiv). Cold Spring Harbor Laboratory 10.1101/2024.07.20.604430
Inglebert, Marine; Dettwiler, Martina; Hahn, Kerstin; Letko, Anna; Drögemüller, Cord; Doench, John; Brown, Adam; Memari, Yasin; Davies, Helen; Degasperi, Andrea; Nik-Zainal, Serena; Rottenberg, Sven (2022). A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer (bioRxiv). Cold Spring Harbor Laboratory 10.1101/2022.09.02.505845
